NeuroPace, Inc.
NPCE
$16.36
-$0.14-0.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.30% | 4.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.30% | 4.42% | |||
| Cost of Revenue | 14.81% | 3.98% | |||
| Gross Profit | 16.74% | 4.56% | |||
| SG&A Expenses | -5.07% | 20.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.29% | 9.66% | |||
| Operating Income | 61.90% | -32.58% | |||
| Income Before Tax | 59.59% | -31.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.59% | -31.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.59% | -31.29% | |||
| EBIT | 61.90% | -32.58% | |||
| EBITDA | 62.39% | -32.78% | |||
| EPS Basic | 59.92% | -25.75% | |||
| Normalized Basic EPS | 59.94% | -25.76% | |||
| EPS Diluted | 59.92% | -25.75% | |||
| Normalized Diluted EPS | 59.94% | -25.76% | |||
| Average Basic Shares Outstanding | 0.83% | 4.39% | |||
| Average Diluted Shares Outstanding | 0.83% | 4.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||